Carcinogenesis and Aging

  • P. N. Magee
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 97)


Apart from certain childhood tumors, cancer in man is a disease of older age groups. Cancer also appears with increasing frequency in older animals.


Chemical Carcinogen Xeroderma Pigmentosum Chemical Carcinogenesis Skin Carcinogenesis Polycyclic Hydrocarbon 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Ponten, J.: Abnormal cell growth (neoplasia) and aging. In: Handbook of the Biology of Aging (Linch, C. and Hayflick, L., eds.) pp. 536–560, Van Nostrand, (1977).Google Scholar
  2. 2.
    Pitot, H. C.: Carcinogenesis and aging-two related phenomena? Amer. J. Path. 87: 444–472 (1977).PubMedGoogle Scholar
  3. 3.
    Schoental, R.: Carcinogenicity as related to age. Ann. Rev. Pharmacol. 14: 185–204 (1974).CrossRefGoogle Scholar
  4. 4.
    Loeb, L.: Cancer and the process of aging. Biol. Symposia 11: 197–216 (1945).Google Scholar
  5. 5.
    Willis, R. A.: Pathology of Tumors, pp. 1019, Butterworths, London, (1967).Google Scholar
  6. 6.
    Miller, R. W.: Prenatal origins of cancer in man: epidemiological evidence. In: Transplacental Carcinogenesis (Tso, P.O.P. and DiPaolo, J., eds.) pp. 61–85, Marcel Dekker, New York, (1974).Google Scholar
  7. 7.
    Clayson, D. B.: Chemical carcinogenesis, pp. 467, Churchill, London, (1962).Google Scholar
  8. 8.
    Blumberg, B. S., Larouze, B., London, W. T., Werner, B., Hesser J. E., Millman, I., Saimot, G. and Payet, M.: The relation of infection with the hepatitis B agent to primary hepatic carcinoma. Amer. J. Path. 81: 669–682 (1975).PubMedGoogle Scholar
  9. 9.
    Doll, R.: Strategy for detection of cancer hazards to man. Nature (London) 265: 589–596 (1977).CrossRefGoogle Scholar
  10. 10.
    Higginson, J.: The role of the pathologist in environmental medicine and public health. Am. J. Path. 86: 460–484 (1977).PubMedGoogle Scholar
  11. 11.
    Boyland, E.: The correlation of experimental carcinogenesis and cancer in man. Progr. Exp. Tumor Res. 11: 222–234 (1969)PubMedGoogle Scholar
  12. 12.
    Doll, R.: Cancer and aging the epidemiological evidence. In: Oncology, vol. 5, pp. 1–28, Yearbook Medical Press, Chicago (1970).Google Scholar
  13. 13.
    Berenblum, I. and Shubik, P.: An experimental study of the initiating stage of carcinogenesis and a re-examination of the somatic cell mutation theory of cancer. Brit. J. Cancer 3: 109–118 (1949).PubMedCrossRefGoogle Scholar
  14. 14.
    Hecker, E.: Definitions and terminology in cancer (tumor) etiology. Z. Krebsforsch. 86: 219–230 (1976).CrossRefGoogle Scholar
  15. 15.
    Butler, W. H. and Jones, G.: Preneoplasia is it an entity? In: Scientific Foundations of Oncology (Symington, T. & Carter, R. L., eds.) pp. 1–7, Heineman, London, (1976).Google Scholar
  16. 16.
    Farber, E.: Carcinogenesis-cellular evolution as a unifying thread. Cancer Res. 33: 2537–2550 (1973).PubMedGoogle Scholar
  17. 17.
    Hard, G. C. and Butler, W. H.: Cellular analysis of renal neoplasia: light microscope study of the development of interstitial lesions induced in the rat kidney by a single carcinogenic dose of dimethylnitrosamine. Cancer Res. 30: 2806–2815 (1970).PubMedGoogle Scholar
  18. 18.
    Miller, E. C. and Miller, J. A.: Mechanisms of chemical carcino- genesis: nature of proximate carcinogens and interactions with macromolecules. Pharmacol. Revs. 18: 805–838 (1966).Google Scholar
  19. 19.
    Miller, J. A.: Carcinogenesis by chemicals: an overview. Cancer Res. 30: 559–576 (1970).PubMedGoogle Scholar
  20. 20.
    Miller, J. A. and Miller, E. C.: Some current thresholds of research in chemical carcinogenesis. In: Chemical Carcinogenesis (Tso, P.O.P. and DiPaolo, J., eds.) pp. 61–85, Marcel Dekker, New York, (1974).Google Scholar
  21. 21.
    Magee, P. N.: Activation and inactivation of chemical carcinogens and mutagens in the mammal. Essays in Biochem. 10: 105–136 (1974).Google Scholar
  22. 22.
    Laqueur, G. L. and Spatz, M.: Toxicology of Cycasin. Cancer Res. 28: 2262–2267 (1968).PubMedGoogle Scholar
  23. 23.
    Nebert, D. W. and Felton, J. S.: Evidence for the activation of 3-methylcholanthrene as a carcinogen in vivo and as a mutagen in vitro by P-450 from inbred strains of mice. In: Cytochromes P-450 and b5 (Cooper, D. Y., Rosenthal, O., Snyder, R. and Witmer, C., eds.) pp. 127–149, Plenum Press, New York and London (1975).CrossRefGoogle Scholar
  24. 24.
    Ames, B. N., Durston, W. E., Yamasaki, E. and Lee, F. D.: Carcinogens are mutagens: a simple test system combining liver homogenates for activation and bacteria for detection. Proc. Nat. Acad. Sci. U. S. 70: 2281–2285 (1973).CrossRefGoogle Scholar
  25. 25.
    Burnet, F. M.: Immunological surveillance in neoplasia. Transplant. Rev. 7: 3–25 (1971).PubMedGoogle Scholar
  26. 26.
    Conney, A. H., Craver, B., Kuntzman, R. and Pantuck, E. J.: Drug metabolism in normal and disease states. In: Pharmacology and Pharmacokinetics (Teorell, T., Dedrick, R. L. and Condliffe, P. G., eds.) pp. 147–162, Plenum Publishing Co. (1974).Google Scholar
  27. 27.
    Kato, R., Vassanelli, P., Frontino, G. and Chiesara, E.: Variation in the activity of liver microsomal drug-metabolizing enzymes in rats in relation to age. Biochem. Pharmacol. 13: 1037–1051 (1964).PubMedCrossRefGoogle Scholar
  28. 28.
    Baird, M. B., Zimmerman, J. A., Massie, H. R. and Pacilio, L. V.: Microsomal mixed-function oxidase activity and senescence. I. Hexobarbital sleep time and induction of components of the hepatic microsomal enzyme system in rats of different ages. Exp. Geront. 10: 89–99 (1975).CrossRefGoogle Scholar
  29. 29.
    Biard, M. B., Birnbaum, L. S. and Massie, H. R.: Decreased rate of hepatic metabolism of benzo[a]pyrene in senescent rats. Proc. Amer. Assoc. Cancer Res. 17: 846 (abs), (1976).Google Scholar
  30. 30.
    Jori, A., DiSalle, E. and Quadri, A.: Rate of aminopyrine disappearance from plasma in young and aged humans. Pharmacology 8: 273–279 (1972).PubMedCrossRefGoogle Scholar
  31. 31.
    Davies, D. L., Bryant, G. M., Arcos, J. C. and Argus, M. F.: Age-dependence of hepatic dimethylnitrosamine-demethylase activity in the rat. J. Nat. Can. Inst. 56: 1057–1058 (1976).Google Scholar
  32. 32.
    Baird, M. B., Zimmerman, J. A., Massie, H. R. and Pcilio, L. V.: Microsomal mixed-function oxidase activity and senescence. H. In vivo and in vitro hepatic drug metabolism in rats of different ages following partial hepatectomy. Exp. Geront. 11:161–165 (1976).CrossRefGoogle Scholar
  33. 33.
    Schwartz, A. G.: Correlation between species life span and capacity to activate dimethylbenz[a]anthracene to a form mutagenic to a mammalian cell. Exp. Cell Res. 94: 445–447 (1975).PubMedCrossRefGoogle Scholar
  34. 34.
    Goth, R. and Rajewsky, M. F.: Persistence of 06-ethylguanine in rat-brain DNA: Correlation with nervous system-specific carcinogenesis by ethylnitrosourea. Proc. Nat. Acad. Sci. U.S.A. 71: 639–643 (1974).CrossRefGoogle Scholar
  35. 35.
    Kleihues, P. and Margison, G. P.: Carcinogenicity of N-methylN-nitrosourea: possible role of excision repair of methylguanine from DNA. J. Nat. Cancer Inst. 53: 1839–1841 (1974).PubMedGoogle Scholar
  36. 36.
    Nicoll, J. W., Swann, P. F. and Pegg, A. E.: Effect of dimethylnitrosamine on persistence of methylated guanines in rat liver and kidney DNA. Nature (london) 254: 261–262 (1975).CrossRefGoogle Scholar
  37. 37.
    Cleaver, J. E. and Bootsma, D.: Xeroderma pigmentosum: biochemical and genetic characteristics. Am. Rev. Genet. 9: 19–38 (1975).CrossRefGoogle Scholar
  38. 38.
    Hart, R. W. and Setlow, R. P.: Correlation between deoxyribonucleic acid excision-repair and life-span in a number of mammalin species. Proc. Nat. Acad. Sci. U.S.A. 71: 2169–2173 (1974).CrossRefGoogle Scholar
  39. 39.
    Roe, F. J. C.: Sensitivity of new born mice to carcinogenic agents. Fd. Cosmet. Toxicol. 6: 581–582 (1968).CrossRefGoogle Scholar
  40. 40.
    Porta, G. and Terracini, B.: Chemical carcinogenesis in infant animals. Prog. Exp. Tum. Res. 11: 334–363 (1969)Google Scholar
  41. 41.
    Baldwin, R. W.: Immunological aspects of chemical carcinogenesis. Advanc. Cancer Res. 18: 1–75 (1973).CrossRefGoogle Scholar
  42. 42.
    Kripke, M. L. and Borsos, T.: Immune surveillance revisited. J. Nat. Cancer Inst. 52: 1393–1395 (1974).PubMedGoogle Scholar
  43. 43.
    Currie, G.: Immunological aspects of host resistance to the development and growth of cancer. Biochim. Biophys. Acta. 458: 135–165 (1976).PubMedGoogle Scholar
  44. 44.
    Rygaard, J. and Povlsen, C. O.: The nude mouse vs. the hypothesis of immunological surveillance. Transplant. Rev. 28: 43–61 (1976).PubMedGoogle Scholar
  45. 45.
    Poel, W. E.: Hormones and Cancer. In: Oncology, vol. 5: pp. 241–250, Yearbook Medical Press, Chicago, (1970).Google Scholar
  46. 46.
    Dilman, V. M.: Age-associated elevation of hypothalamic threshold to feedback control, and its role in development, aging and disease. Lancet L: 1211–1219, (1971).PubMedCrossRefGoogle Scholar
  47. 47.
    Meranze, D. R., Gruenstein, M. and Shimkin, M. B.: Effect of age and sex on the development of neoplasms in Wistar rats receiving a single intragastric instillation of 7,12-dimethylbenz[a]anthracene. Internat. J. Cancer 4: 480–486 (1969).CrossRefGoogle Scholar
  48. 48.
    Forbes, P. D.: Experimentally-induced neoplasms in the skin of mice II. The influence of age on tumor induction in rhino mice. J. Invest. Dermatol. 44: 399–407, (1965).PubMedGoogle Scholar
  49. 49.
    Van Duuren, B. L., Sivak, A., Katz, C., Seidman, I. and Melchionne, S.: The effect of aging and interval between primary and secondary treatment in two-stage carcinogenesis on mouse skin. Cancer Res. 35: 502–505 (1975).PubMedGoogle Scholar
  50. 50.
    Ebbesen, P.: Papilloma induction in different aged skin grafts to young recipients. Nature (London) 241: 280–281 (1973).CrossRefGoogle Scholar
  51. 51.
    Ebbesen, P.: Aging increases susceptibility of mouse skin to DMBA carcinogenesis independent of general immune status. Science 183: 217–218 (1974).PubMedCrossRefGoogle Scholar
  52. 52.
    Lee, P. N. and Peto, R.: The effect of the age of mice on the incidence of skin cancer. Brit. J. Cancer 24: 849–852 (1970).PubMedCrossRefGoogle Scholar
  53. 53.
    Peto, R., F. J. C., Lee, P. N., Levy, L. and Clack, J.: Cancer and aging in mice and man. Brit. J. Cancer 32: 411–426 (1975).PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York  1978

Authors and Affiliations

  • P. N. Magee
    • 1
  1. 1.Fels Research Institute and Department of PathologyTemple University School of MedicinePhiladelphiaUSA

Personalised recommendations